Progress in myasthenia gravis.
D000109:Acetylcholine / Q000096:biosynthesis; D000328:Adult; D000368:Aged; D000818:Animals; D001323:Autoantibodies; D001984:Bronchial Neoplasms / Q000175:diagnosis; D018288:Carcinoma, Small Cell / Q000175:diagnosis; D003937:Diagnosis, Differential; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000175:diagnosis; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000276:immunology / Q000378:metabolism / Q000628:therapy; D009388:Neostigmine / Q000627:therapeutic use; D009469:Neuromuscular Junction / Q000378:metabolism; D011300:Preoperative Care; D051381:Rats; D013934:Thymectomy; D013953:Thymus Neoplasms / Q000150:complications
D001323:Autoantibodies; D009388:Neostigmine; D000109:Acetylcholine